Please assess the completion status of the following clinical trial:

Trial Title: ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men and women, age 22 years and older~* Subjects who are able and willing to give informed consent and able to attend all study visits~* Subjects with a diagnosis of Essential Tremor as confirmed from clinical history and examination by a neurologist or neurosurgeon specialized in movement disorder~* Subject exhibits a significant disability from their ET despite medical treatment~* Subjects should be on a stable dose of all ET medications for 30 days prior to study entry~* Subject is able to communicate sensations during the ExAblate Transcranial procedure~Exclusion Criteria:~* Subjects with unstable cardiac status~* Severe hypertension~* Subjects with standard contraindications for MR imaging such as non-MRI compatible implanted metallic devices including cardiac pacemakers, size limitations, etc.~* Known intolerance or allergies to the MRI contrast agent including advanced kidney disease or severely impaired renal function~* Significant claustrophobia that cannot be managed with mild medication~* Current medical condition resulting in abnormal bleeding and/or coagulopathy~* Receiving anticoagulant (e.g. warfarin) or antiplatelet (e.g. aspirin) therapy within one week of focused ultrasound procedure or drugs known to increase risk or hemorrhage~* History of intracranial hemorrhage~* History of multiple strokes, or a stroke within past 6 months~* Subjects who are not able or willing to tolerate the required prolonged stationary supine position during treatment~* Are participating or have participated in another clinical trial in the last 30 days~* Subjects unable to communicate with the investigator and staff~* Subjects with a history of seizures within the past year~* Subjects with brain tumors

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Transcranial ExAblate (Type: EXPERIMENTAL): Transcranial ExAblate
- Sham Transcranial ExAblate (Type: SHAM_COMPARATOR): Sham Treatment with Transcranial ExAblate

Based on this trial design, predict the completion outcome and termination type (if applicable).